Scientists have shown for the first time that tumour DNA shed into the bloodstream can be used to track cancers in real time as they evolve and respond to treatment, according to a new Cancer Research UK study published in the journal Nature Communications.
Over three years, researchers at the University of Cambridge took surgical tumour samples (biopsies) and blood samples from a patient with breast cancer that had already spread to other parts of her body. They carefully studied small fragments of DNA from dying tumour cells that are shed into the blood, comparing them with DNA from the biopsy that was taken at the same point in time.
The results show that the DNA in the blood samples matched up with that from the biopsies, reflecting the same pattern and timing of genetic changes appearing as the cancer developed and responded to treatment. The results provide the first proof-of-principle that analysing tumour DNA in the blood can accurately monitor cancer within the body.
Study author Professor Carlos Caldas, senior group leader at the Cancer Research UK Cambridge Institute, said: “This definitively shows that we can use blood-based DNA tests to track the progress of cancer in real time. The findings could change the way we monitor patients, and may be especially important for people with cancers that are difficult to reach, as taking a biopsy can sometimes be quite an invasive procedure.”
The patient in the study had breast cancer that had already spread to a number of other organs. The researchers – part of a collaborative team effort involving the Carlos Caldas and Nitzan Rozenfeld laboratories at the Cancer Research UK Cambridge Institute – were even able to distinguish between the different secondary cancers and examine how each of the tumours was responding to treatment.
Professor Caldas added: “We were able to use the blood tests to map out the disease as it progressed. We now need to see if this works in more patients and other cancer types, but this is an exciting first step.”
Read more:Â DNA in blood can track cancer development and response in real time
The Latest on: Track cancer development
[google_news title=”” keyword=”Track cancer development” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Track cancer development
- 'Fight back': Community celebrates cancer survivors at Relay For Lifeon May 14, 2024 at 7:00 am
Relay For Life and the American Cancer Society came together on Friday night at the Athens SportsPlex to commemorate their continuous fight against cancer by honoring the lives of those ...
- FDA Grants Fast Track Designation to SNB-101 in SCLCon May 13, 2024 at 7:30 am
SNB-101, a nanoparticle drug for small cell lung cancer, received a fast track designation from the FDA for expedited development and review.
- FDA Speeds Up Review of Novel Small Cell Lung Cancer Drugon May 13, 2024 at 6:00 am
The Food and Drug Administration will speed up its review of SNB-101 to treat patients with small cell lung cancer.
- Development of Stomach’s Acid-Secreting Cells Requires ERR-gammaon May 10, 2024 at 3:12 pm
Researchers acknowledge that the sole reliance on a single gene (Esrrg) for PC specification and maturation is unexpected ...
- SN Bioscience Receives FDA Fast Track Designation for Small Cell Lung Canceron May 9, 2024 at 8:59 pm
SN Bioscience Co. Ltd. (CEO Park Young-hwan) announced on May 7 that the FDA has granted Fast Track Designation for small cell lung cancer (SCLC) for SNB-101 (API: SN-38), a new drug for polymer ...
- 9MW2821 Gains FDA Orphan Drug Designation in Esophageal Canceron May 9, 2024 at 1:09 pm
MW2821 was granted an orphan drug designation from the FDA and is being evaluated for the potential treatment of esophageal cancer, as well as other cancers.
- Horoscope For Each Zodiac Sign On May 10 — The Moon Enters Canceron May 9, 2024 at 12:00 pm
For Friday's horoscopes, the Moon leaves gabby Gemini to enter the quieter zodiac sign of Cancer. The Moon rules Cancer, and while in its home sign, it provides soft, gentle energy. The weekend kicks ...
- National Cancer Research Month: 7 CU Boulder discoveries that could improve, save liveson May 8, 2024 at 10:03 am
From developing new therapies to help patients cope with anxiety to discovering new ways to treat resistant breast cancer and new environmentally friendly methods for producing chemotherapy drugs, CU ...
- CG Oncology Touts Bladder Cancer Complete Response Rate for Immunotherapyon May 6, 2024 at 6:50 am
Following an upsized IPO earlier this year, CG Oncology on Friday posted promising Phase III data for cretostimogene, which elicited a 75% complete response rate in high-risk non-muscle invasive ...
- Meet the scientist sending tumors into spaceon May 5, 2024 at 5:00 pm
We can track cancer when it starts to clone itself ... and small molecules to block all of these properties like cancer development and accelerated stem cell aging … in space and then bring ...
via Bing News